Release of growth-differentiation factor 15 and associations with cardiac function in adult patients with congenital heart disease

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 246-251

  Eindhoven, J A ^a   Van Den Bosch, A E ^a   Oemrawsingh, R M ^a   Baggen, V J ^a   Kardys, I ^a   Cuypers, J A ^a   Witsenburg, M ^a   Van Schaik, R H ^a   Roos Hesselink, J W ^a   Boersma, E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adult congenital heart disease; Echocardiography; Growth differentiation factor 15; Ventricular function

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GROWTH DIFFERENTIATION FACTOR 15; TROPONIN T;

ADULT; AORTA COARCTATION; AORTA STENOSIS; ARTERIAL SWITCH OPERATION; ARTICLE; ARTIFICIAL HEART PACEMAKER; BICYCLE ERGOMETRY; BLOOD SAMPLING; BODY MASS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FALLOT TETRALOGY; FEMALE; FONTAN PROCEDURE; FUNCTIONAL STATUS; HEART ARRHYTHMIA; HEART FAILURE; HEART FUNCTION; HEART RATE; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; HYPERTENSION; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN SECRETION; PULMONARY HYPERTENSION; QRS INTERVAL; SYSTOLIC BLOOD PRESSURE; VEIN PUNCTURE; BLOOD; DISEASE COURSE; EXERCISE TEST; EXERCISE TOLERANCE; FOLLOW UP; HEART DEFECTS, CONGENITAL; LUNG WEDGE PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ADULT; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; GROWTH DIFFERENTIATION FACTOR 15; HEART DEFECTS, CONGENITAL; HUMANS; MALE; PULMONARY WEDGE PRESSURE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION;

EID: 84960156585     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.09.010     Document Type: Article

References (19)

1. M.R. Bootcov, A.R. Bauskin, S.M. Valenzuela, and et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily Proc. Natl. Acad. Sci. U. S. A. 94 1997 11514 11519
2. J. Corre, B. Hebraud, and P. Bourin Concise review: growth differentiation factor 15 in pathology: a clinical role? Stem Cells Transl. Med. 2 2013 946 952
3. T. Kempf, M. Eden, J. Strelau, and et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ. Res. 98 2006 351 360
4. C.A. Krusche, B. Holthofer, V. Hofe, and et al. Desmoglein 2 mutant mice develop cardiac fibrosis and dilation Basic Res. Cardiol. 106 2011 617 633
5. J. Xu, T.R. Kimball, J.N. Lorenz, and et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ. Res. 98 2006 342 350
6. D.J. Lok, I.T. Klip, S.I. Lok, and et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor-15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-T) in patients with advanced chronic heart failure Am. J. Cardiol. 112 2013 831 837
7. I.S. Anand, T. Kempf, T.S. Rector, and et al. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial Circulation 122 2010 1387 1395
8. O. Tutarel, A. Kempny, R. Alonso-Gonzalez, and et al. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality Eur. Heart J. 35 2014 725 732
9. K. Norozi, R. Buchhorn, A. Yasin, and et al. Growth differentiation factor 15: an additional diagnostic tool for the risk stratification of developing heart failure in patients with operated congenital heart defects? Am. Heart J. 162 2011 131 135
10. T.M. Raedle-Hurst, K. Koenigstein, F. Gruenhage, and et al. Growth differentiation factor 15 - an early marker of abnormal function of the Fontan circuit in patients with univentricular hearts Am. Heart J. 160 2010 1105 1112
11. R.M. Lang, M. Bierig, R.B. Devereux, American Society of Echocardiography's Nomenclature, Standards Committee, Task Force on Chamber Quantification, American College of Cardiology Echocardiography Committee, American Heart Association, European Association of Echocardiography, European Society of Cardiology, and et al. Recommendations for chamber quantification Eur. J. Echocardiogr. 7 2006 79 108
12. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
13. J.A. Eindhoven, A.E. van den Bosch, T.P. Ruys, and et al. N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease J. Am. Coll. Cardiol. 62 2013 1203 1212
14. R. Inuzuka, G.P. Diller, F. Borgia, and et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term Circulation 125 2012 250 259
15. N. Nickel, T. Kempf, H. Tapken, and et al. Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension Am. J. Respir. Crit. Care Med. 178 2008 534 541
16. T. Kempf, E. Bjorklund, S. Olofsson, and et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Eur. Heart J. 28 2007 2858 2865
17. T. Kempf, S. von Haehling, T. Peter, T. Allhoff, M. Cicoira, W. Doehner, P. Ponikowski, G.S. Filippatos, P. Rozentryt, H. Drexler, S.D. Anker, and K.C. Wollert Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure J. Am. Coll. Cardiol. 50 2007 1054 1060
18. X. Xu, Z. Li, and W. Gao Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside Biomarkers 16 2011 466 475
19. M. West-hoff-Bleck, E. Podewski, O. Tutarel, and et al. Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: a single-centre experience Int. J. Cardiol. 2013 433 438